Literature DB >> 15381925

Expanding the 'central dogma': the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophrenia.

D O Perkins1, C Jeffries, P Sullivan.   

Abstract

It is now evident that nonprotein coding RNA (ncRNA) plays a critical role in regulating the timing and rate of protein translation. The potential importance of ncRNAs is suggested by the observation that the complexity of an organism is poorly correlated with its number of protein coding genes, yet highly correlated with its number of ncRNA genes, and that in the human genome only a small fraction (2-3%) of genetic transcripts are actually translated into proteins. In this review, we discuss several examples of known RNA mechanisms for the regulation of protein synthesis. We then discuss the possibility that ncRNA regulation of schizophrenia risk genes may underlie the diverse findings of genetic linkage studies including that protein-altering gene polymorphisms are not generally found in schizophrenia. Thus, inadequate or mistimed expression of a functional protein may occur either due to mutation or other dysfunction of the DNA coding base pair sequence, leading to a dysfunctional protein, or due to post-transcriptional events such as abnormal ncRNA regulation of a normal gene. One or more 'schizophrenia disease genes' may turn out to include abnormal transcriptional units that code for RNA regulators of protein coding gene expression or to be proximal to such units, rather than to be abnormalities in the protein coding gene itself. Understanding the genetics of schizophrenia and other complex neuropsychiatric disorders might very well include consideration of RNA and epigenetic regulation of protein expression in addition to polymorphisms of the protein coding gene.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15381925     DOI: 10.1038/sj.mp.4001577

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  30 in total

Review 1.  Oxidative damage to RNA in aging and neurodegenerative disorders.

Authors:  Akihiko Nunomura; Paula I Moreira; Rudy J Castellani; Hyoung-Gon Lee; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Neurotox Res       Date:  2012-06-06       Impact factor: 3.911

Review 2.  Unravelling the world of cis-regulatory elements.

Authors:  Zhao Wang; Gong-Hong Wei; De-Pei Liu; Chih-Chuan Liang
Journal:  Med Biol Eng Comput       Date:  2007-05-31       Impact factor: 2.602

3.  Recent computational approaches to understand gene regulation: mining gene regulation in silico.

Authors:  I Abnizova; T Subhankulova; Wr Gilks
Journal:  Curr Genomics       Date:  2007-04       Impact factor: 2.236

Review 4.  Epigenetic principles and mechanisms underlying nervous system functions in health and disease.

Authors:  Mark F Mehler
Journal:  Prog Neurobiol       Date:  2008-10-17       Impact factor: 11.685

Review 5.  MicroRNAs in addiction: adaptation's middlemen?

Authors:  M D Li; A D van der Vaart
Journal:  Mol Psychiatry       Date:  2011-05-24       Impact factor: 15.992

6.  MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders.

Authors:  Albert H Kim; Mark Reimers; Brion Maher; Vernell Williamson; Omari McMichael; Joseph L McClay; Edwin J C G van den Oord; Brien P Riley; Kenneth S Kendler; Vladimir I Vladimirov
Journal:  Schizophr Res       Date:  2010-08-02       Impact factor: 4.939

Review 7.  Emerging roles for ncRNAs in alcohol use disorders.

Authors:  R Dayne Mayfield
Journal:  Alcohol       Date:  2017-04-15       Impact factor: 2.405

8.  Striatal microRNA controls cocaine intake through CREB signalling.

Authors:  Jonathan A Hollander; Heh-In Im; Antonio L Amelio; Jannet Kocerha; Purva Bali; Qun Lu; David Willoughby; Claes Wahlestedt; Michael D Conkright; Paul J Kenny
Journal:  Nature       Date:  2010-07-08       Impact factor: 49.962

Review 9.  Group II metabotropic glutamate receptors and schizophrenia.

Authors:  José L Moreno; Stuart C Sealfon; Javier González-Maeso
Journal:  Cell Mol Life Sci       Date:  2009-08-26       Impact factor: 9.261

10.  Sublethal RNA oxidation as a mechanism for neurodegenerative disease.

Authors:  Rudy J Castellani; Akihiko Nunomura; Raj K Rolston; Paula I Moreira; Atsushi Takeda; George Perry; Mark A Smith
Journal:  Int J Mol Sci       Date:  2008-05-20       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.